4-(3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propyl)morpholine, 95.0%, 250mg

(2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-(3-carboxypropanamido)-2-methylpentanoic acid, 97.0%, 25mg

trans-N-Fmoc-1,4-cyclohexanediaime hydrochloride, 97.0%, 5g

N-(4-chloropyridin-3-yl)-4-((2,2-difluorobenzo[d][1,3]dioxol-5-yl)Methyl)piperazine-1-carboxaMide, 100mg

tert-Butyl 1-cyclopentylpiperidin-4-ylcarbamate, 95.0%, 10g

2-(3,4-Dihydroxyphenyl)-N-(prop-2-yn-1-yl)acetamide, 95.0%, 250mg

Plateaux pour tubes d'élution ROTI®, MINI, 1 pièce(s)

N-Propanoyl mannosamine, 99.0%, 1g

3-(Chloromethyl)-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridine, 98%, 100mg

(1R,2R,3S,4S,5R,6S)-7-OXABICYCLO[4.1.0]HEPTANE-2,3,4,5-TETRAOL, 97%, 100mg

ethyl 4-cyclohexyl-2-hydroxy-4-oxobut-2-enoate, 98%, 2.5g

3,4-Diiodo-5-methyl-1H-pyrazole, 98.0%, 1g

N-Ethylmaleimide, 98.0%, 100g